申请人:WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.
公开号:US20200170966A1
公开(公告)日:2020-06-04
The present invention relates to use of an aminomethylenecyclohexane-1,3-dione compound, more particularly to use of a compound shown in the following formula (I) or a pharmaceutically acceptable salt thereof alone or in combination with other drug in preparing a drug for regulating or treating a disease related to autophagy, especially mammalian ATG8 homologous proteins.
本发明涉及使用氨甲基环己烷-1,3-二酮化合物,更具体地涉及使用以下式(I)所示的化合物或其药学上可接受的盐单独或与其他药物结合,用于制备用于调节或治疗与自噬相关的疾病,特别是哺乳动物ATG8同源蛋白的药物。